PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FCL06
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $14,865
Award facts
- Contract value 100% obligated
- $14,865.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $14,865.12, was awarded on January 14, 2026, to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc., through a competitive, non-set-aside procurement process. The award falls under the Defense Logistics Agency Troop Support Medical's Indefinite Delivery Contract (IDC SPE2DX), a $1 billion vehicle valued through December 2026 that serves as the pharmaceutical prime vendor for military healthcare systems worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—which is also the place of performance for this order—is a major pharmaceutical distributor supplying an extensive range of medications, vaccines, and medical supplies to federal agencies, particularly the Defense Health Agency and U.S. Coast Guard.
The delivery order reflects AmerisourceBergen Drug Corp's ongoing role as a critical vendor within the Defense Logistics Agency's pharmaceutical supply chain. As a firm fixed-price delivery order, this contract represents a single transaction within the larger IDC framework, consistent with the company's typical federal procurement pattern of fulfilling medical supply needs across multiple therapeutic domains. Funding for this award originates from the Medical Supply Chain within the Department of Defense, underscoring the strategic importance of pharmaceutical distribution to military readiness and veteran healthcare operations. The contract concludes on January 15, 2026, with no set-aside designation applied.
Quick answers
Who was awarded contract SPE2D826FCL06?
SPE2D826FCL06 was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 14, 2026.
How much is contract SPE2D826FCL06 worth?
The government has obligated $14,865 on SPE2D826FCL06.
Is contract SPE2D826FCL06 an order under another contract?
Yes. SPE2D826FCL06 is a delivery order under SPE2DX22D0019, an indefinite delivery contract.
Was contract SPE2D826FCL06 competed?
The extent of competition for SPE2D826FCL06 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award